Locations:
Search
Insights on integrating behavioral health providers into care as the disease progresses
Study demonstrates its role in tumor lethality, raises prospect of therapeutic targets
Guidance on instructing patients, treatment selection, impact of disease course and more
Who is at risk? What tests should be ordered?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
$1.1M award expands follow-up to six years with focus on clinical endpoints
Guidance for the 5% to 20% of patients with suboptimal response or tolerability
Diagnosis and treatment of MOG antibody-associated disease
Care guidelines have been crucial to progress in TBI care over the past 25 years
Mounting evidence of possible shared genetic predisposition
Recently launched first-of-kind study aims to address an unmet therapeutic need
Advertisement
Advertisement